• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) of the formula <IMAGE> wherein R1 is lower straight-chain or branched-chain mono- or polyhydroxyalkyl; R2 is hydrogen, lower alkyl or R1; R3 is hydrogen or lower alkyl; and X is a direct bond or straight-chain or branched-chain alkylene interrupted by one or more oxygen or substituted by hydroxy or lower alkyl, are useful in x-ray contrast media.
    公开号:SU917696A3
    申请号:SU772498151
    申请日:1977-06-22
    公开日:1982-03-30
    发明作者:Пфайффер Хайнрих；Шпек Ульрих
    申请人:Шеринг Аг (Фирма)；
    IPC主号:
    专利说明:

    Compounds of ionic type (salts of 2,., 6-triyodobenzoic acids) and non-ionic compounds (for example, Mettrieamide-2 (3 acetamido-5-N-methyl-acetami to -2, 6-triiodobenimido) -2-deoxy- D-glucose) type. This method is based on the well-known reaction of obtaining acid amides by the interaction of acid chlorides with amines 1. 5 Using tetracarboxylic acid as a starting tetrachloride anhydride of the general formula
    where RJ and X have the above values, it allows to obtain new compounds with improved properties
    The purpose of the invention is to obtain new compounds of general formula 1 with radiopaque contrast.
    This goal is achieved by the fact that in the process of obtaining new compounds of the formula t, tetrachloroanhydride of tetracarboxylic acid of general formula II is reacted with an amine of formula HNR, where R and Rj have the above values
    PRI me R 1. (2, -dioxypropyl-N-methyl-carbamoyl) -2, A, 6-triiodoanilide oxalic acid.
    A. A solution of 103 g of 5-amino-triiodoisophthalic acid dichloride in 412 ml of dioxane on oil at an internal temperature of 80-90 C for 10 min is added dropwise with stirring and 10.3 ml of oxalic acid dichlorohydride. After stirring overnight at room temperature, the precipitate is filtered off with suction and dried in the absence of moisture. The yield of crude di- (3B-dichlorocarbonyl-2, A, 6-: triiodoanide) of oxalic acid is 88.5 g (73) 6 per theory, taking into account
    dioxane content 10 wt.%) Does not decompose to.
    B. A solution of 88.5 g of the above tetracarboxylic acid tetrachloride in 1.77 l of dioxane is mixed with 90 g of N-methylamino-2, 3-propanediol and 177 ml of water at room temperature with good stirring and stirred for 8 h at , room temperature. Then the emulsion is concentrated to dryness. The oily residue is stirred three times with isopropanol, while taking 900 ml each time, sucked off and dried. After that, it is dissolved in 1 l of water and passed through a column with a cation catalyst. From the first fractions, 102 g of oil is isolated, which, dissolved in 1 l of water, is passed through an anion exchanger. From the first fractions after treatment with coal and concentration, 5b g (58 from theory), 5-bis- (2, 3o-dioxypropyl-M-methyl-carbamoyl) -2, 6-triiodoylide of oxalic acid are obtained; M.p. with decomposition of 307-312 C.
    Solubility in water more than 60 g / 100 ml of solution at room temperature.
    The data of elemental analysis are given in table.1.
    Table 1
    3.01 50.23 5.71
    26.55 2.23 56, 6, k3 23, "9 25, 2.84 54.81 6.05 Example 2. 5c-t3, 5-bic- (2-oxi ilccarbamoyl) -2, C, 6- iodanil oxalic acid. A suspension of 28 g of di- (3.5 dichlorocarbonyl-2, k, 6-triiodoanilide) oxalic acid with a dioxane content of -10 (prepared according to example 1A) in 400 ml of dioxane with stirring is mixed dropwise with a solution of 6.1G of this nolamine in 50 ml of water and simultaneously with a solution of 10 g of potassium bicarbonate in 50 ml of water. After being stirred overnight, the suspension was concentrated in vacuo to dryness and the resulting oil triturated with 100 ml of ethanol under heating. Upon cooling, the product crystallizes out. It is stirred with 130 ml of water, sucked off and dried. The yield of bis (2-hydroxyethylcarbamoyl) -2, δ, 6-triiodoanal spicylate acid is 2Q, kg (76% of theories). Does not decompose to 320 C. Example 3., (2-oxyethyl-M-methyl-carbamoyl) -2,4,6 triiodoanyl / 1 oxalic acid. A solution of 12.5 g (calculated without dioxane) di- (3 5 Dichloroparabonyl-2, 6-triiodoanilide) oxalic acid in 1 BO ml of dioxane is mixed with 10 g of N-methylethanolamine. After stirring overnight, the dioxane is decanted, the oily residue is mixed with water and the pH is adjusted to 1 with hydrochloric acid. After stirring overnight, the precipitate is filtered off with suction. The output is 7, g (52.9 from theory). Decomposition from /.goc. Example k. , 5- (N, N-bis- (2-hydroxyethyl) -carbamoyl) -2, t, 6-triiodoanil oxalic acid / utah. Prepared analogously to example 3 from TO mmol of di- (3.5 dichlorocarbonyl-2, k, 6-triiodoanilide) oxalic acid and 120 mmol of ethanolamine. The treatment is carried out analogously to Example 3. Yield: 6%; m.p. 320 C (with decomposition). Example 5., 5-bis- (2-hydroxyethylcarbamoyl) -2, 6-triiodo id of oxalic acid. The suspension. 2, Eg (calculated without dioxane) di- (g, 5 Dichlorocarbonyl-2, C, 6-triiodoanil oxalic acid in 125 ml of dimethylformamide is mixed with 15 g of ethanolamine. When self-heating to 55 ° C, a solution is formed. After many hours of stirring, the solvent is distilled off. in vacuo, the oily residue is mixed with 250 ml of water and acidified with hydrochloric acid to pH 1. The precipitate O7 is aspirated and stirred with water. Yield 26, g (98.2 per theory) bis 3, (2-hydroxyethylcarbamoyl) -2 , k, 6-triiodoanyl DA of oxalic acid. Does not decompose to. Example 6. Bisc, 5 bis- (3-hydroxypropylcarbamoyl) -2, ft, 6-trii danilide oxalic acid. Prepared analogously to example 5 of 10 mmol of di- {3,5-dichlorocarbonyl-2, 4,6-triiodoanilide oxalic acid and 120 mmol 3 of aminopropanol. The yield is 63%, decomposes at a temperature above 280 ° C. Example 7. Bis- 3,5-bis- 2-hydroxypropylcarbamoyl) -2 .i, 6-triiodanilide oxalic acid. Prepared analogously to example 5 of 10 mmol of di- (3,5-dichlorocarbonyl-2, 6-triiodoanilide) oxalic acid and t20 mmol of .1-amino-2-propanol. Yield 35% m.p. З20с (with decomposition). Example 8. Bis-3,5-bis- (2 ,, dioxypropyl-M-methyl-carbamoyl).-2,4,6-triiodo-M-methyl-anilide oxagl taroic acid. A. A solution of 110 g of 5-methylamino-2,4,6-triiodisophthalic acid dichlorohydrin in PO ml of dioxane with stirring dropwise at 80 ° C is mixed with 18.5 g of 2-oxaglutaric acid dichlorohydride. The mixture is then refluxed for 5.5 hours, and a precipitate forms. HIS is sucked off after 20 hours of stirring. Yield: 60.5 g (51% of theory) of bis-3, 5 bis-chlorocarbonyl-2,4,6-triiodo-N-methyl-anilide Zoxogluthanoic acid. Decomposition at about 300 C, the content of dioxane is less than 0.5. . . Found,%: CE 11.3; 3 57.7. Calculated: C1 10.76) 3 57.73. B. With vigorous stirring, a solution of 31.5 r.N-methylaminopropanediol-2, 3 in 60 ml tetrahydrofuran is added dropwise to a solution of 39.7 g of the above-mentioned tetracarboxylic acid tetracarbonic acid tetracarboxylic acid tetrahydrofuran. A precipitate forms a precipitate, from which tetra-hydrofuran is decanted after stirring overnight. The precipitate is dissolved in 400 ml of water and passed through a column with 500 g of a Catalum Exchange (for example, IR 120). Condensed to a volume of 400 ml, eluates are passed through 500 g of anion exchanger (for example, IRA 410). The combined eluates are concentrated, treated with charcoal and concentrated to dryness. Yield: 37.7. g (% of theory; 5bis- (2,3-dioxypropyl-N-methyl-carbamoyl) -2,4,6-tri-Bd-N-methyl-anilide oxaglutaric acid .- Decomposition from 222c. Solubility in water above bOg / 100 ml solution. Approx. 9., 5-bis- (2, 3-dioxypropyl-N-methyl-carbamoyl) -2, 4,6-triiod-M-methyl-anilide malonic acid. A. A solution of 30.5 g 5 methylamino-2,4,6,6-triiodoisophthalic acid dichloride in 45 ml of dioxane at the boiling point under reflux is slowly mixed with 4.2 g of malonyl chloride and heated for 3 hours. After cooling, the precipitate is sucked off Yield: 25.8 g (80 from theory) bis- (3,5 bis-chloro-carbo Il-2,4,6triiod-M-methyl-anilide) malonic acid. Dioxane content 0.8.T.P.P. above B. Suspension 20 g of the above-mentioned tetracarboxylic acid tetrachloroanhydride in 2BO ml of tetrahydrofuran is mixed with a solution of 16.3 g N-methylaminopropanol in 40 ml of terrahydrofuran for 24 hours. Then the oily raw product (as in example 8 V) is treated in a pure form by treatment with ion exchangers. Yield: 22 g (91% of theory) bis- f2 , 5-6Hc- (2,3-dioxypropyl-M-iethylcarbamoyl) -2,4,6-triyod-M-methyl-anilide of malonic acid, so pl. 233-25 / C. Solubility in water is higher than bOg / 15 0 ml of solution. PRI me R 10., 5-bis- (2,3-dioxipropyl-N-methyl-carbamate) -2,4,6-tripiolone adipic acid. A .. In a solution of 221 g of dichlorohydrin in 5-amino-triiodoisophthalic acid in 320 ml of dioxane at reflux temperature, 41 g of adipic acid dichloride are added dropwise. After heating for 3 hours and after cooling overnight, the resulting precipitate is sucked off. Yield: 1b9 g (67 from the theory) of bis- (3.5 bis-chlorocarone-2, 6-triiodoanilide) adipic acid with 6% dioxane, decomposition from. B. In analogy to Example 8B, a solution of 133 g of tetracarboxylic acid chlorohydride obtained in 1000 ml of tetrahydrofuran is mixed with a solution of 101 g of N-methylaminopropane diol in 300 ml of tetrahydrofuran and, after stirring overnight, is purified by dissolving the greasy raw product. in water and chromatography on ion exchangers. . Output: 98.2 g (6A% of theory), (2,3 dioxypropyl-n-methyl-carbamoyl) -2,4,6-triiodoanyl adipic acid, so pl. 233-24 ° C. Solubility in water 13. The compound gives supersaturated solutions. Example 11. Bis- 3,5 bis- (1 3-dioxyisopropylcarbamoyl) -2 ,, 6-triiodoanyl adipic acid .. A mixture of 27.6 g of bis- (3,5-bis-chlorocarbonyl-2, k, 6- tri-6-danilide) 9 dipic acid and 18 g of 1,3-dioxy-iso-primyl amine in 2 O of tetrahydrofuran are intensively stirred for 48 hours, then sucked off and stirred with water. .. Output: 21, 3 g (70 from theory) by-C - 5-bis- (1, 3-dioxy-: isopropylcarbamoyl) -2,4,6-triiodoanilide and dipycinic acid. Decomposition above 300 ° C, solubility in water ilk 0.1%. Example 12., 5-bis- (2, -dioxypropyl-M-methyl-carbamoyl) -2, 4,6-triiodanilide Z.b-dioxypropanoic acid. A. To a solution of 119 g of 5-amino-triiodoisophthalic acid dichloride in 119 ml of dioxane at the boiling point of NIKOM reflux 23.8 g of dioxane acid dichlorohydride. After heating for 6 hours and cooling overnight, the resulting precipitate is filtered off with suction. Yield: 75 g (52% of theory) of bis- (H, 5-bis-chlorocarbonyl-2,4,6 tririo anilide) 3,6-dioxabrobic acid with 6.8% dioxane, decomposition at 260-262 C. B. A solution of 71 g of tetracarboxylic acid chloride obtained above and 35 g of tributylamine in 375 ml of dimethylacetamide are heated to 50 ° C and mixed with a solution of 26 g of N-methylaminopropane diol in 200 ml of dimethylacetamide. After stirring for another 4 hours and cooling overnight, the solvent was distilled off in vacuo and the residue was stirred with methylene chloride. The product insoluble in methylene chloride is dissolved in 750 ml of water and purified using ion exchanger columns as in Example 8 B. Yield: 45 g (56 of theory-) bisC3, 5-bis-, 3-dioxypropyl-N-methyl-carbamoyl ) -2,4,6-triiodoanilide 13,6-dioxabrobic acid. Mp.214220C (decomposition) is approximately 13. Bis- {3,5 bis- (2,3 dioxypropyl-M-methyl-carbamoyl) -2,4,6-triyod-N-methyl-anilide succinic acid .. A. A solution of 30.5 g of methylamino-2,4,6-triiodisophthalic acid dichloride in 50 ml of dioxane is heated under reflux by slowly adding 4.65 g of succinic acid dichloride, and then continued to be heated for 3 hours. After cooling the precipitate is sucked off. The yield of bis- (3,5 bis-chlorocarbonyl-2, 4,6-triiodide-M-methyl-anilide) succinic acid is 25.7 g (78% of theory). The dioxane content is 1%, so pl. above 300 ° C. Found,%: CE 11.26, 3 58, ZB Calculated: C 10.90, D § 8.50 B. Analogously to Example 8. B A suspension of 21.8 g of the above tetracarboxylic acid tetrachloroanhydride in 200 ml of tetrahydrofuran is reacted with 17.5 g of N-methylaminopropane-2, 3, dissolved in 50 ml of tetrahydrofuran, and treated with a cation-exchanger and anion-exchanger. The yield of bis (5-bis- (2,3-dioxypropyl-N-methyl-carbamoyl) -2,4,6-triiod-N-methyl-dindyl succinic acid 20.7 g (78.61 from theory). T 241-246 C. Solubility in water is 60 g / 100 ml of solution .. Example 14., 5-bis- (2,3-Dioxyprpyl-M-methyl-carbamoyl) -2,4,6-triiodoanilide methyl smallNEW ACIDS; A. A solution of 29.8 g of 5-amino-2,4,6-triiodo-isophthalic acid dichloride in 30 ml of dioxane by heating 7 with reflux, slowly added 6 g of methylmalonic acid dichlorohydride, and continue to heat for another hour. the precipitate is sucked off.
    Output, 5-6is- (chlorocarbonyl) -2, 6-triiodoanilide methylmalonic acid 13.8 g (kQ% of theory). The dioxane content is 7.8. M.p. 278-28 ° C.
    Found: cr 11, 20, 3 59, 36.
    Calculated D: (t 11, U; 3 59,73
    B. In analogy to Example 12 B 2, g of the above tetracarbonic acid tetrachloride in 76 ml of dimethylacetamide and 22.8 g of tributylamine are reacted with 10.1 g of K-methylaminopropanediol-2,3.
    The yield of bis-b; 5-bis- (2,3-dioxipropyl-N-methyl-carbamoyl) -2, t, 6-three-triiodo-methyl methylmalonic acid and, 8 g (50% of theory). 2b9271 C (with decomposition). Water solubility over 60 g / 100 ml solution.
    Example 15. 5-bis- (2,3-dioxmpropyl-N-3-methylcarbamoyl) -2,4,6-triiodoanilide 3-methyl adipic acid.
    A. A solution of 29.8 g of 5-amino-2,4,6-triiodo-isophthalic acid dichloride in 30 ml of dioxane is heated under reflux, 5.9 g of 3-methyladipine acid dichloride are slowly added and then continue to be heated t for hours. cooling the precipitate is sucked off.
    Yield, 5-bis- (chlorocarbonyl) -2, 6-triiodoanilide 3-methyladipic acid 21.9 g (63.2% of theory.). The dioxane content is 5.1%. Decomposition from.
    B. In analogy to Example 12B, 20 g of the above tetracarboxylic acid tetrachloride in 61 ml of dimethylacetamide and 18.1 g of tributylamine are reacted with 8 g of N-methyl, propanediol-2,3 and further processed.
    Yield, 5-bis- (2,3-Dioxy-. Propyl-N-methyl-carbamoyl) -2, t, 6-triiodoanylide 3-methyladipic acid 15.6 g (6.5% of theory). M.p. 2 1-265 0.
    Found,%: About 48.3Calculated, 3 A7.88.
    Water solubility more bog / ml solution., Example 16., 5-bis-fl, 1-bis- (hydroxymethyl 1-methylcarbamoyl -2, 4,6-triiodoanilide) 3,6,9-trioxaundecanedicarboxylic acid.
    A solution of 29.8 g of 5-amino-2, 6-triiodoisophthalic acid dichlorohydride in 30 ml of dimethylacetamide at 60 ° C, mixed with 7.8 g of dichlorohydrin, 9-tripyroxyndecanecane diboric acid and stirred for 5 hours at 60 C. After dilution, dilute 5 h. dimethylacetamide is added dropwise. at 50 ° C, g of serinol in 75 ml of dimethylacetamide, 38 g of tributylamine are added and the mixture is stirred at 50 ° C. After adding 20 ml of con-;
    5 centered hydrochloric acid
    the solution is mixed with methylene chloride. The product insoluble in methylene chloride is dissolved in 300 ml of water and purified in ion exchange columns as in Example 8.
    The yield of bis-3,5-bis- l, 1 -bis- (hydroxymethyl) -methylcarbamoyl -2, triiodoanilide-3, 6.3 trioxaundecanedicarboxylic acid (33.3% of,
    theories). M.p. 180-188 C. Solubility in water more than 60 g / 10 ml of solution.
    Example 17., 5-bis0 (, A, 5,6 -pentoxixiexyl-i-methylcarbamoyl -2, 4,6-triiodoyl adipic acid.
    Heated to a suspension of 98 g of N-methylglucamine in 250 ml of dimethylacetamide is added dropwise a suspension of 5, 1 g, 5-bic (6-triacanone) 2, 6-triiodoanilide in 180 ml of dimethylacetamide. The reaction mixture is stirred at 50 ° C for 4 hours, and a precipitate forms after a temporary solution, and is stirred at room temperature overnight. At the end of the course, 11 ml of concentrated hydrochloric acid. The Nmethylglucamine hydrochloride precipitated is sucked off, washed with dimethylacetamide and discarded. The filtrates are evaporated together in vacuo at 5 mm Hg. The residue is dissolved in 650 ml of water and, analogously to example 1, is fed through a cationic anion exchanger. When the eluate is concentrated, a residue is formed, which is stirred with 650 ml of ethanol for 5 hours at room temperature.
    Yield-bis-3,5-bis- (2,3, .5,6-pentaoxyhexyl-L-methylcarbamoyl) -2,, 6-triiodoanide (dipedic acid} 65G (75. from theory). T. pl. 192 -20 ° C. 3 Example 18. Preparation of an isonic solution with the compound of Example 8. Bis- (3,5-bis- (2,3 dioxypropyl-M-methyl-carbamoyl) -2, A, 6-triiodo-N-methyl anilide oxaglutaric acid b2.7 g NaCt0.2 g Ca, Ma | -edetate 0.01 g Bidly distilled water Up to 150 m 1N NaOH solution to establish pH7 The solution is poured into vials and ampoules and sterilized. Iodine content 300 mg / ml. 290 m Osm, respectively 7.5 atm. Example 19. Obtaining an Isometric p in a human serum. - (2, .3 dirxypropyl-M-methyl-carbamoyl) -2,, 6-triiodoanilide) oxalic acid59, 890, 022 KC10.032 MgCli6HiO0.017 NaHCO O "050 NaCl0.170 Naj-zedat0.010 1 N NaOH solution to establish a pH of 7 The solution is filled with sterile or then sterilized. The iodine content is 300 mg / ml. Suspension at 290 m Osm, respectively 7.5 atm. The new compounds of general formula 1 have a reduced osmotic pressure as compared with the known compounds of a similar effect. Table 2 shows the concentration, osmotic pressure and chemical capacity in solutions with the same iodine concentration (300 mg iodine / ml) for compounds of various types. table 2
    1591769616
    The new compounds differ in noble, meglumiociromat or metridar of their negligible toxicity, as shown in Table 3 for the example of compounds D, E, and And compared with the known drugs megluminidotrizoatum, meglumminiotalam
     Determined using supersaturated solution.
    I. Compatibility after intravenous injection ..
    Test contrast agents are injected intravenously in the form of solutions, in general, ionic in the form of meglumine salts at a concentration of 300 mg iodine / ml and at a dose of 10 g iodine / kg at an injection rate of 0.8 ml / min to 6-10 mice weighing 20 -22 g. It is shown that after the injection of ionic contrast agents, all animals die and after the injection of metrizamide 1 animal dies. With the introduction of the new compound D, all mice survive.
    II. Protein binding. Contrast Binding
    with human plasma proteins, at a final plasma concentration of 1.2 mg iodine / ml using the method of ular filtration, New, neonzamide, a number of other useful properties: compatibility after intravenous injection, low affinity
    to protein, a slight effect of 5 on red blood cells.
    The dimer D is bound only in. very insignificant measure (1 ,,). Comparative substances exhibit, on the contrary, a higher affinity for protein. Protein binding is undesirable for contrast agents used in angiography,
    5 urography and myelography.
    Iii. Effect on red blood cells. Solutions of contrast agents with a concentration of 300 mg iodine / ml are mixed in a 1: 6 ratio with heparinized blood. The final concentration of the contrast agent is 43 mg iodine / ml. As an estimate of 1 (the criteria is the change in the natural form of red blood cells through
    S echinocytes. In spherocytes. The estimated number for intact (intact) erythrocytes is O, the estimated number for the maximum degree of reversal is 7696
    Cases - 5- New, non-ionic dimer, D causes the lowest red blood cell damage with a distance.
    Co-x-Co-N / Ya
    des lower, having a straight or branched chain mono or polyoxyalkyl residue 2-6. carbon atoms with 1-5 hydroxy groups; R. is a hydrogen atom or a lower alkyl residue with 1-2 carbon atoms, substituted or unsubstituted by a hydroxyl group
    Coct
    a-so
    Ctco
    3 where X is as defined above, is reacted. with an amine of the formula: where R and R. are as defined above. ;
    权利要求:
    Claims (1)
    [1]
    The invention The method of producing bis- (3 5-dicarbamoyl -2,1,6-triiodoanilides) dicarboxylic acids of the general formula 1
    -RA
    -II /
    Co-n
    Yag
    Rj is a hydrogen atom or methyl
    Group; X is a simple bond or (CHt) with
    n from 1 to (.) l
    with n 1 to 3t or
    -CH-CH-CH -CHNH
    due to the fact that
    about t and
    tetracarboxylic acid chloride
    Formulas II
    k Sources of information taken into account in the examination 1. Buhler; K., Pearson I. Organic syntheses. Part 2, M., Mir, 1973, p. 388.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU917696A3|1982-03-30|Process for producing bis-| of dicarboxylic acids
    CA1160243A|1984-01-10|Tri-iodised 5-aminoisophthalic acid derivatives
    US2750393A|1956-06-12|Iodinated 5-henzamidotetrazoles and preparation thereof
    Berlin et al.1968|. alpha.-Aminoarylmethylphosphonic acids and diethyl. alpha.-aminoarylmethylphosphonate hydrochlorides. Aluminum-amalgam reduction of oximes of diethyl aroylphosphonates
    EP0015867A1|1980-09-17|Diamides of triiodo-isophthalic acids, their preparation and X-ray contrast agents containing them
    WO2004099224A1|2004-11-18|Carboplatin-type platinum | complexes
    US5665343A|1997-09-09|Polymeric platinum complex, preparation thereof, and anticancer agent comprising thereof
    US4748254A|1988-05-31|Mixed carboxylato platinum | complexes
    SU776561A3|1980-10-30|Method of preparing alpha-aminophosphonic acids
    DE1645921C3|1978-10-12|2-Oxo-13,2-osazaphosphorinane, process for their preparation and pharmaceutical preparations containing them
    DE249241C|1912-07-13|
    SU784763A3|1980-11-30|Method of preparing 6-methoxy-2-acetylnaphthyloxime derivatives of their hydrochlorides
    DE2644905C3|1979-11-22|Process for the preparation of optically active 2- [bis- | -amino] -1-oxa-3-aza-2phosphacyclohexane oxide-2
    US4886790A|1989-12-12|Novel bis| phosphinic amides for use in the treatment of tumors
    EP0112871A1|1984-07-11|Derivatives of n,n-bis|-phosphoric acid amide.
    DE3323316A1|1984-10-18|BIS- | PHOSPHINIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME
    US3096373A|1963-07-02|N, n&#39;-bis | dicarboxylic acid amides
    US4129660A|1978-12-12|Derivatives of cis-epoxy-1,2-propyl-phosphonic acid and drugs containing in particular as active ingredients derivatives of cis-epoxy-1,2-propylphosphonic acid in dextrorotatory form
    DE3111025C2|1989-12-07|
    DE2638804C3|1979-02-22|Amidophosphorothiolates, process for their preparation and their use as a herbicide
    RU2186068C2|2002-07-27|Method of purification of cis-dichloroamminiso-propylaminplatinum |
    JP2920212B1|1999-07-19|Method for producing 1,3-dioxolan-4-one compound
    WO1997044343A1|1997-11-27|Phosphorus containing cythesine derivatives
    DE1445659C|1973-08-30|Pyndyl phosphorus compounds and processes for their preparation
    SU1558918A1|1990-04-23|Method of purifying amides or amido esters of phosphoric | acids from amine hydrohalogenides
    同族专利:
    公开号 | 公开日
    DK595284A|1984-12-12|
    AU512304B2|1980-10-02|
    ATA443777A|1980-07-15|
    FI67540B|1984-12-31|
    JPS6232185B2|1987-07-13|
    NO147447B|1983-01-03|
    PL199019A1|1978-03-28|
    PT66690B|1978-11-17|
    AU2632577A|1979-01-04|
    NO148811B|1983-09-12|
    IL52356D0|1977-08-31|
    ES460007A1|1978-05-01|
    JPS537637A|1978-01-24|
    FR2355808A1|1978-01-20|
    LU88292I2|1994-05-04|
    CA1106401A|1981-08-04|
    NO772202L|1977-12-27|
    SE7707230L|1977-12-24|
    SE436871B|1985-01-28|
    DK595284D0|1984-12-12|
    CA1106400A|1981-08-04|
    IT1237314B|1993-05-29|
    NO822674L|1977-12-27|
    NL7705509A|1977-12-28|
    ZA773782B|1978-05-30|
    CH629751A5|1982-05-14|
    FR2355808B1|1979-03-09|
    BE856039A|1977-12-23|
    IL60344D0|1980-09-16|
    DK266177A|1977-12-24|
    PL108102B1|1980-03-31|
    IE45225B1|1982-07-14|
    DK165973C|1993-07-26|
    DK150505B|1987-03-16|
    NL189510C|1993-05-03|
    IE45225L|1977-12-03|
    IE45226B1|1982-07-14|
    FI67540C|1985-04-10|
    FI771900A|1977-12-24|
    LU77588A1|1977-09-29|
    NL189510B|1992-12-01|
    PT66690A|1977-07-01|
    NO147447C|1983-04-13|
    CS199680B2|1980-07-31|
    DK165973B|1993-02-22|
    DE2628517A1|1978-01-05|
    HU174228B|1979-11-28|
    NO148811C|1983-12-21|
    IE45226L|1982-07-14|
    IL52356A|1981-03-31|
    DE2628517C2|1985-02-21|
    GR71696B|1983-06-21|
    GB1588734A|1981-04-29|
    US4239747A|1980-12-16|
    JPS61126059A|1986-06-13|
    DD131014A5|1978-05-24|
    DK150505C|1988-01-11|
    AT361117B|1981-02-25|
    JPS6111220B2|1986-04-01|
    GB1588733A|1981-04-29|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US2853424A|1952-08-06|1958-09-23|Schering Ag|X-ray contrast agents comprising symmetrical bifunctional analogs of nu-acyl derivatives of 2, 4, 6 triiodo-3-amino benzoic acid|
    US3178473A|1962-03-02|1965-04-13|Nyegaard & Co As|Process for the n-alkylation of acyl anilides halogen substituted in the nucleus|
    FR3975M|1963-03-06|
    GB1033777A|1963-06-06|1966-06-22|Sterling Drug Inc|Bis-anilide derivatives|
    US3732293A|1968-03-15|1973-05-08|Sterling Drug Inc|Iodinated bis and esters thereof|
    CH502104A|1968-05-02|1971-01-31|Bracco Ind Chimica Spa|New X-ray contrast media and processes for their production|
    NL153083B|1969-06-27|1977-05-16|Nijegaard & Co A S|PROCESS FOR PREPARING TRIJODENZOIC ACID AMIDES.|
    US3660464A|1970-06-19|1972-05-02|Squibb & Sons Inc|Tri-iodinated diaminobenzoic acid derivatives|
    BE787669A|1971-08-17|1973-02-19|Schering Ag|N-METHYL-DICARBOXYLIC ACID TRIIODS ANILIDES AND THEIR PREPARATION PROCESS|
    DD104193A5|1972-12-22|1974-03-05|
    DE2629228C2|1976-06-25|1984-10-18|Schering AG, 1000 Berlin und 4709 Bergkamen|Iodinated isophthalamic acid derivatives Process for their production and their use|
    CH626873A5|1977-03-28|1981-12-15|Bracco Ind Chimica Spa|CH626873A5|1977-03-28|1981-12-15|Bracco Ind Chimica Spa|
    DK273280A|1979-06-28|1980-12-29|Schering Ag|TRIODED 5-AMINOISOPHTHALIC ACID DERIVATIVES|
    IT1193211B|1979-08-09|1988-06-15|Bracco Ind Chimica Spa|2,4,6-TRIIODE-ISOPHTHALIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND CONTRAST MEANS THAT CONTAIN THEM|
    IT1207226B|1979-08-09|1989-05-17|Bracco Ind Chimica Spa|2,4,6-TRIIODE-ISOPHTHALIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND CONTRAST MEANS THAT CONTAIN THEM.|
    JPH0136474B2|1980-01-31|1989-07-31|Yunibaashitei Obu Karifuorunia|
    US4341756A|1980-01-31|1982-07-27|The Regents Of The University Of California|Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media|
    DE3038853A1|1980-10-10|1982-05-27|Schering Ag, 1000 Berlin Und 4619 Bergkamen|NEW N-HYDROXY-ALKYLATED DICARBONIC ACID-BIS- , THEIR PRODUCTION AND THEIR CONTAINING X-RAY CONTRAST AGENTS |
    LU88639I2|1982-11-08|1996-02-01|Nycomed Imaging S A|Contrast agents for x-rays|
    FR2541272A1|1983-02-23|1984-08-24|Guerbet Sa|BROMINE COMPOUNDS AND OPACIFIER PRODUCTS CONTAINING THEM|
    US4650903A|1984-06-21|1987-03-17|The Bf Goodrich Company|Oligomeric amides as synergists for antioxidants and UV stabilizers|
    DE3731542A1|1987-09-17|1989-03-30|Schering Ag|NEW DICARBONIC ACID-BIS , METHOD FOR THE PRODUCTION THEREOF AND THESE CONTAINING X-RAY AGENTS|
    DE3739098A1|1987-11-16|1989-05-24|Schering Ag|NEW SUBSTITUTED DICARBONIC ACID-BIS , METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING X-RAY CONTRASTING AGENTS|
    US5075502A|1989-12-13|1991-12-24|Mallinckrodt, Inc.|Nonionic x-ray contrast agents, compositions and methods|
    IT1252180B|1991-12-10|1995-06-05|Bracco Ind Chimica Spa|5,5 '-BISACETYLIMINE) -BIS , THEIR METHOD OF PREPARATION AND ROENTGENOGRAPHIC CONTRAST MEANS THAT CONTAIN THEM|
    CN1038725C|1993-12-04|1998-06-17|吉林省鹊源国际生物工程有限公司|Nutritious oral liquor|
    US6149891A|1995-05-31|2000-11-21|Israel Humanitarian Foundation Ltd.|X-ray contrast medium and method for protecting against harmful effects thereof|
    IT1299202B1|1998-05-08|2000-02-29|Dibra Spa|PROCESS FOR THE PREPARATION OF S-N, N'-BISETHYL) -5 -AMINO) -2,4,6-TRIIODE|
    US7790141B2|2003-08-11|2010-09-07|Pathak Holdings, Llc|Radio-opaque compounds, compositions containing same and methods of their synthesis and use|
    CN103951585A|2007-07-12|2014-07-30|通用电气医疗集团股份有限公司|Contrast agents|
    US20100209356A1|2007-10-12|2010-08-19|Duncan George Wynn|Contrast agents|
    JP2011500530A|2007-10-12|2011-01-06|ジーイー・ヘルスケア・アクスイェ・セルスカプ|Contrast agent|
    EP2200656B1|2007-10-12|2012-12-05|GE Healthcare AS|Contrast agents|
    JP2011500532A|2007-10-12|2011-01-06|ジーイー・ヘルスケア・アクスイェ・セルスカプ|Contrast agent|
    CN101842120A|2007-10-30|2010-09-22|通用电气医疗集团股份有限公司|Contrast agents|
    JP2011509943A|2008-01-14|2011-03-31|マリンクロッド・インコーポレイテッド|Process for preparing iosimenol|
    WO2012136813A2|2011-04-07|2012-10-11|Universitetet I Oslo|Agents for medical radar diagnosis|
    EP3220887A1|2014-11-21|2017-09-27|Technical University of Denmark|Gel formulations for local drug release|
    AU2017266410A1|2016-05-20|2018-11-22|Nanovi Radiotherapy Aps|Palpable marker composition|
    WO2020249801A1|2019-06-12|2020-12-17|Technical University Of Denmark|Dissacharide formulations for controlled drug release|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE2628517A|DE2628517C2|1976-06-23|1976-06-23|Dicarboxylic acid biscompounds, process for their preparation and X-ray contrast media|
    [返回顶部]